Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator

Satoshi Miyamoto, Cheng Chih Hsu, Gregory Hamm, Manjula Darshi, Maggie Diamond-Stanic, Anne Emilie Declèves, Larkin Slater, Subramaniam Pennathur, Jonathan Stauber, Pieter C. Dorrestein, Kumar Sharma

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

AMP-activated protein kinase (AMPK) is suppressed in diabetes and may be due to a high ATP/AMP ratio, however the quantitation of nucleotides in vivo has been extremely difficult. Via matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to localize renal nucleotides we found that the diabetic kidney had a significant increase in glomerular ATP/AMP ratio. Untargeted MALDI-MSI analysis revealed that a specific sphingomyelin species (SM(d18:1/16:0)) accumulated in the glomeruli of diabetic and high-fat diet-fed mice compared with wild-type controls. In vitro studies in mesangial cells revealed that exogenous addition of SM(d18:1/16:0) significantly elevated ATP via increased glucose consumption and lactate production with a consequent reduction of AMPK and PGC1α. Furthermore, inhibition of sphingomyelin synthases reversed these effects. Our findings suggest that AMPK is reduced in the diabetic kidney due to an increase in the ATP/AMP ratio and that SM(d18:1/16:0) could be responsible for the enhanced ATP production via activation of the glycolytic pathway.

Original languageEnglish
Pages (from-to)121-134
Number of pages14
JournalEBioMedicine
Volume7
DOIs
Publication statusPublished - May 1 2016

Fingerprint

Sphingomyelins
Adenosine Monophosphate
Medical problems
Mass spectrometry
Mass Spectrometry
Obesity
Adenosine Triphosphate
AMP-Activated Protein Kinases
Imaging techniques
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Kidney
Ionization
Desorption
Nucleotides
Mesangial Cells
Lasers
High Fat Diet
Nutrition
Lactic Acid
Chemical activation

Keywords

  • AMPK
  • ATP
  • Chronic kidney disease
  • Glycolysis
  • Matrix-assisted laser desorption/ionization mass spectrometry imaging
  • Sphingomyelin

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator. / Miyamoto, Satoshi; Hsu, Cheng Chih; Hamm, Gregory; Darshi, Manjula; Diamond-Stanic, Maggie; Declèves, Anne Emilie; Slater, Larkin; Pennathur, Subramaniam; Stauber, Jonathan; Dorrestein, Pieter C.; Sharma, Kumar.

In: EBioMedicine, Vol. 7, 01.05.2016, p. 121-134.

Research output: Contribution to journalArticle

Miyamoto, S, Hsu, CC, Hamm, G, Darshi, M, Diamond-Stanic, M, Declèves, AE, Slater, L, Pennathur, S, Stauber, J, Dorrestein, PC & Sharma, K 2016, 'Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator', EBioMedicine, vol. 7, pp. 121-134. https://doi.org/10.1016/j.ebiom.2016.03.033
Miyamoto, Satoshi ; Hsu, Cheng Chih ; Hamm, Gregory ; Darshi, Manjula ; Diamond-Stanic, Maggie ; Declèves, Anne Emilie ; Slater, Larkin ; Pennathur, Subramaniam ; Stauber, Jonathan ; Dorrestein, Pieter C. ; Sharma, Kumar. / Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator. In: EBioMedicine. 2016 ; Vol. 7. pp. 121-134.
@article{603ccc8c9912488c8a6364c50e0b9256,
title = "Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator",
abstract = "AMP-activated protein kinase (AMPK) is suppressed in diabetes and may be due to a high ATP/AMP ratio, however the quantitation of nucleotides in vivo has been extremely difficult. Via matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to localize renal nucleotides we found that the diabetic kidney had a significant increase in glomerular ATP/AMP ratio. Untargeted MALDI-MSI analysis revealed that a specific sphingomyelin species (SM(d18:1/16:0)) accumulated in the glomeruli of diabetic and high-fat diet-fed mice compared with wild-type controls. In vitro studies in mesangial cells revealed that exogenous addition of SM(d18:1/16:0) significantly elevated ATP via increased glucose consumption and lactate production with a consequent reduction of AMPK and PGC1α. Furthermore, inhibition of sphingomyelin synthases reversed these effects. Our findings suggest that AMPK is reduced in the diabetic kidney due to an increase in the ATP/AMP ratio and that SM(d18:1/16:0) could be responsible for the enhanced ATP production via activation of the glycolytic pathway.",
keywords = "AMPK, ATP, Chronic kidney disease, Glycolysis, Matrix-assisted laser desorption/ionization mass spectrometry imaging, Sphingomyelin",
author = "Satoshi Miyamoto and Hsu, {Cheng Chih} and Gregory Hamm and Manjula Darshi and Maggie Diamond-Stanic and Decl{\`e}ves, {Anne Emilie} and Larkin Slater and Subramaniam Pennathur and Jonathan Stauber and Dorrestein, {Pieter C.} and Kumar Sharma",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.ebiom.2016.03.033",
language = "English",
volume = "7",
pages = "121--134",
journal = "EBioMedicine",
issn = "2352-3964",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator

AU - Miyamoto, Satoshi

AU - Hsu, Cheng Chih

AU - Hamm, Gregory

AU - Darshi, Manjula

AU - Diamond-Stanic, Maggie

AU - Declèves, Anne Emilie

AU - Slater, Larkin

AU - Pennathur, Subramaniam

AU - Stauber, Jonathan

AU - Dorrestein, Pieter C.

AU - Sharma, Kumar

PY - 2016/5/1

Y1 - 2016/5/1

N2 - AMP-activated protein kinase (AMPK) is suppressed in diabetes and may be due to a high ATP/AMP ratio, however the quantitation of nucleotides in vivo has been extremely difficult. Via matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to localize renal nucleotides we found that the diabetic kidney had a significant increase in glomerular ATP/AMP ratio. Untargeted MALDI-MSI analysis revealed that a specific sphingomyelin species (SM(d18:1/16:0)) accumulated in the glomeruli of diabetic and high-fat diet-fed mice compared with wild-type controls. In vitro studies in mesangial cells revealed that exogenous addition of SM(d18:1/16:0) significantly elevated ATP via increased glucose consumption and lactate production with a consequent reduction of AMPK and PGC1α. Furthermore, inhibition of sphingomyelin synthases reversed these effects. Our findings suggest that AMPK is reduced in the diabetic kidney due to an increase in the ATP/AMP ratio and that SM(d18:1/16:0) could be responsible for the enhanced ATP production via activation of the glycolytic pathway.

AB - AMP-activated protein kinase (AMPK) is suppressed in diabetes and may be due to a high ATP/AMP ratio, however the quantitation of nucleotides in vivo has been extremely difficult. Via matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to localize renal nucleotides we found that the diabetic kidney had a significant increase in glomerular ATP/AMP ratio. Untargeted MALDI-MSI analysis revealed that a specific sphingomyelin species (SM(d18:1/16:0)) accumulated in the glomeruli of diabetic and high-fat diet-fed mice compared with wild-type controls. In vitro studies in mesangial cells revealed that exogenous addition of SM(d18:1/16:0) significantly elevated ATP via increased glucose consumption and lactate production with a consequent reduction of AMPK and PGC1α. Furthermore, inhibition of sphingomyelin synthases reversed these effects. Our findings suggest that AMPK is reduced in the diabetic kidney due to an increase in the ATP/AMP ratio and that SM(d18:1/16:0) could be responsible for the enhanced ATP production via activation of the glycolytic pathway.

KW - AMPK

KW - ATP

KW - Chronic kidney disease

KW - Glycolysis

KW - Matrix-assisted laser desorption/ionization mass spectrometry imaging

KW - Sphingomyelin

UR - http://www.scopus.com/inward/record.url?scp=84963543334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963543334&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2016.03.033

DO - 10.1016/j.ebiom.2016.03.033

M3 - Article

C2 - 27322466

AN - SCOPUS:84963543334

VL - 7

SP - 121

EP - 134

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

ER -